600
Participants
Start Date
April 1, 2024
Primary Completion Date
January 31, 2025
Study Completion Date
April 30, 2025
1-week predisone+1-week celecoxib
20 and 10 mg prednisone in the morning and afternoon, respectively, daily for 1 week; in the second week, these participants received 400 mg celecoxib (a type of nonsteroidal anti-inflammatory drug) on day 1 and 200 mg twice daily for the remaining 6 days until celecoxib withdrawal.
6-weeks predisone
20 and 10 mg prednisone in the morning and afternoon, respectively, daily in the first week, and then reduced by 5 mg/week from the second week until withdrawal in the sixth week.
Xinqiao Hospital of Chongqing
OTHER